Balloon valvuloplasty in dysplastic pulmonary valve stenosis: immediate and intermediate outcomes

Tayyaba Sehar1, Ahmad Usaid Qureshi1, Uzma Kazmi1

  • 1Department of Paediatric Cardiology, The Children's Hospital and Institute of Child Health, Lahore.

Insights

Balloon valvuloplasty for dysplastic pulmonary valve stenosis in children yielded suboptimal outcomes compared to doming valves. However, it offers good intermediate freedom from re-intervention, suggesting intervention at moderate severity may improve results.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Pulmonary valve stenosis (PVS) is a common congenital heart defect.
  • Dysplastic PVS and doming PVS represent distinct anatomical subtypes with potentially different treatment outcomes.
  • Balloon valvuloplasty is a primary intervention for severe PVS in children.

Purpose of the Study:

  • To compare immediate and intermediate outcomes of balloon valvuloplasty in children with dysplastic PVS versus doming PVS.
  • To identify factors associated with unsuccessful outcomes and re-intervention in pediatric PVS treated with balloon valvuloplasty.

Main Methods:

  • An interventional study conducted at The Children's Hospital, Lahore, Pakistan (June 2006 - December 2012).
  • 152 children with severe PVS underwent balloon valvuloplasty, categorized into dysplastic (Group A, n=73) and doming (Group B, n=79) types.
  • Outcomes were assessed based on residual gradient, re-intervention rates, and factors influencing success using statistical analysis (t-test, Mann Whitney U, Chi square, Kruskal-Wallis, multivariate analysis, Kaplan-Meier).

Main Results:

  • Mean gradient reduced from 96 ± 33 mmHg to 29 ± 20 mmHg post-procedure.
  • Dysplastic PVS (Group A) showed a higher rate of unsuccessful outcomes (9.6%, p=0.02) compared to doming PVS (Group B).
  • Pre-procedure gradient > 75 mmHg was linked to unsuccessful outcomes, while immediate post-procedure gradient > 60 mmHg predicted re-intervention in Group A. Freedom from re-intervention at 6 years was 78.9% for Group A vs. 96.5% for Group B.

Conclusions:

  • Balloon valvuloplasty for dysplastic PVS in children yields less optimal results than for doming PVS.
  • Despite this, dysplastic PVS treatment demonstrates a high intermediate freedom from re-intervention.
  • Considering intervention at moderate PVS severity may lead to improved outcomes.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
396
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
513
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.3K